The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine

Por Walsby, Elisabeth J., Coles, Steven J., Knapper, Steven, Burnett, Alan K.
Publicado em 2011

The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells

Por Walsby, Elisabeth, Pearce, Lawrence, Burnett, Alan K., Fegan, Chris, Pepper, Chris
Publicado em 2012

A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine

Por Walsby, Elisabeth, Pratt, Guy, Shao, Hao, Abbas, Abdullah Y., Fischer, Peter M., Bradshaw, Tracey D., Brennan, Paul, Fegan, Chris, Wang, Shudong, Pepper, Chris
Publicado em 2013

Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73

Por Lam, Frankie, Abbas, Abdullahi Y., Shao, Hao, Teo, Theodosia, Adams, Julian, Li, Peng, Bradshaw, Tracey D., Fischer, Peter M., Walsby, Elisabeth, Pepper, Chris, Chen, Yi, Ding, Jian, Wang, Shudong
Publicado em 2014